Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may reduce sweating by blocking

Gland-bound may suppress by blocking despite normalized . Failure of extracted antibodies to transfer blocking activity, with recovery of bound antibodies confirmed, would reject the hypothesis.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Biological function

The biological function description is being prepared

Direction

Lens

Puts the cause outside the part under study, in the wider system and the conditions it sits in.System and environment

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Самоограничение регенерации при повторных циклах восстановления
Competing hypotheses
3
Published
2026-09-25
As a hypothesis
9 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
3 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Antibody

    that bind the muscarinic and block its function

    Where this hypothesis actsAssociated with sweat glands showing persistent loss after normalization of skin

    Hypotheses on this target 1
    M3 receptor autoantibodiesLower level. Hypotheses on this target 11Protection from degradation. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Neutralisation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0
    • Lower level1
    • Protection from degradation
    • Synthesis suppression
    • Neutralisation
    • Accelerated excretion

    What is proposed

    Lower level

    Prevent from blocking the

    With whatRemoval from a body fluid

    HowRemove the -binding while keeping tissue stiffness, duct patency and cholinergic stimulation unchanged

    Possible result

    Possible restoration of the sweat component of

    From the recordУдаление блокирующих антител должно восстановить потовый компонент SPV_8 без изменения жёсткости и проходимости протока.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodies
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Sweating might remain impaired even after the skin’s stiffness returns to normal. The unexpected move is to locate the continuing problem in antibodies, immune proteins that bind particular targets, rather than in a lasting physical change around the gland. That is a proposal generated by this pipeline, not a measured result.

The proposed mechanism, link by link
  1. Antibodies already associated with the gland are proposed to bind its .
  2. That binding is proposed to block receptor function rather than merely mark the receptor’s presence.
  3. Blocked receptors are predicted to respond less to the same concentration of a -stimulating substance even after tissue recover.
  4. The weakened receptor response is proposed to keep low despite an open duct.
  5. Removing the blocking antibodies is predicted to restore without changing stiffness or duct openness.
A picture for it

A doorbell button can remain jammed after the surrounding doorframe has been straightened. Pressing it just as hard still produces no ring until the obstruction is removed.

Where the picture breaks: A receptor is not a mechanical button, and an that binds it need not block it. The picture also cannot distinguish reduced sweat production from sweat being lost on its way through the duct.

  1. Master questionstep 01 of 04

    The goal is a treatment that restores the skin function of middle-aged people to the condition found in young people.

    Rests on: The supplied goal sets younger skin function as the desired outcome but does not define the functions or measurements that would establish success.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Repeated rounds of repair are framed as limiting the skin’s ability to regenerate.

    Rests on: The move from restoring younger skin function to repeated repair requires repeated repair to contribute to the functional limitation of interest.

    Assumption

    The chain takes repeated repair and its self-limiting effects as relevant to the middle-aged skin problem; the master goal does not establish that connection.

  3. Gap questionstep 03 of 04

    Cells around sweat glands might retain , a persistent effect of earlier physical loading, that reduces sweating after average skin stiffness returns to normal. Local relief of that loading is proposed as a way to examine recovery while keeping the signal that stimulates unchanged.

    Rests on: The preceding stage identifies limits after repeated repair, but does not connect those limits to persistent changes around sweat glands.

    Leap

    The supplied chain does not establish that repeated repair produces this persistent sweating defect, or that normal average stiffness can coexist with the proposed local .

  4. Hypothesisstep 04 of 04

    , antibodies directed against the body’s own targets, are proposed to remain associated with sweat glands and block function. Removing them is predicted to restore sweating without changing stiffness or the openness of the , the passage carrying sweat to the skin surface.S1S4

    Rests on: The preceding question supplies the problem of sweating remaining low after recover. Two screened sources supply separate grounds for considering : Neurology in 2011 reported reduced protein alongside disturbances including sweating, but did not establish blockade; PloS one in 2013 reported recognition of in patients with an skin disease, but did not establish impaired sweating or functional blockade.

    Supported by literature

What is carried, and what is not. Screened sources speak to two separate ingredients: an association between reduced protein and disturbed sweating, and recognition of ; neither establishes blocking activity in the glands at issue. No supplied source establishes the sequence from gland-associated antibodies through persistent loss of sweating after mechanical recovery to restoration after removal.

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain takes repeated repair and its self-limiting effects as relevant to the middle-aged skin problem; the master goal does not establish that connection.
  • Gap question. The supplied chain does not establish that repeated repair produces this persistent sweating defect, or that normal average stiffness can coexist with the proposed local . Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Suppression transferred with an preparation could be attributed to blockade even if another substance in the preparation causes it; binding alone also does not establish blocking activity. What closes it: The proposed removal and return of the -binding portion must be paired with controls that undergo the same processing without that removal. Loss and return of suppression must be measured in both the receptor test system and control glands, while a separately verified route that stimulates without remains functional.
  • Failure to transfer suppression could be read as evidence against the hypothesis when the extraction failed to recover the antibodies bound to the gland. What closes it: Recovery of gland-bound antibodies must be confirmed before a negative transfer result counts against the proposal, as its stated falsification condition requires. The preparation and recipient test system must also permit blocking activity to be detected.
  • Sweat measured at the surface could be treated as a direct measure of gland production, although the supplied duct explanation allows water to return to surrounding tissue through an open duct. What closes it: Sweat production and water loss through the duct must be distinguished alongside surface output. Unchanged stiffness and duct openness alone do not exclude this rival; the supplied specification does not describe a separate measurement of that water loss.

What would make this wrong. The proposal’s stated decisive counter-observation is absence of after confirmed recovery of gland-bound antibodies in a test capable of detecting that activity. That would break the proposed explanation of persistent reduced sweating, without disproving the broader goal of restoring younger skin function.

What it would change. If the proposal held, restoring physical conditions around sweat glands would leave an -dependent cause of reduced sweating untreated. Work toward younger skin function would then need to distinguish this cause from persistent physical changes, loss of water through ducts and faults within secreting cells. Even successful transfer, removal and restoration tests would not establish that this mechanism commonly limits sweating in middle-aged people, or that treating it restores the broader skin function sought by the master question.

Sources read · 8

4 literature searches, 6 full texts, 3 abstract-only; 9 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. · Neurology · 2011

“The disease pattern was characterized by disturbances in micturition, pupil constriction, body weight, and sudomotor function, with normal accommodation, gastrointestinal motility, salivation, and lacrimation, similar to features of male M3 knockout mice. M3 protein quantity was reduced.”

Does not settle: This source does not establish gland-associated anti-M3 autoantibodies, functional receptor blockade, reduced response to a cholinergic stimulus after mechanical normalization, or recovery of sweating after antibody removal.

S2BackgroundAbstract only

Pathophysiology and emerging treatments for dermographic, cholinergic and cold urticaria. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2026

“These include activating receptors such as the high-affinity IgE receptor (FcεRI), Mas-related G protein-coupled receptor X2 (MRGPRX2) and muscarinic cholinergic receptor M3 (CHRM3), as well as emerging roles for neuropeptides, autoantibodies and sweat allergens.”

Does not settle: Источник не устанавливает, что аутоантитела связываются с M3-рецептором потовых желёз, функционально его блокируют, снижают ответ на холинергический стимулятор или что удаление антител восстанавливает потовый компонент SPV_8 при неизменной механике.

S3BackgroundAbstract only

New autoantibodies in Sjögren's disease. · Current opinion in immunology · 2026

“Notably, autoantibodies targeting functional proteins like the muscarinic M3 receptor (anti-M3R) have demonstrated high diagnostic sensitivity and specificity.”

Does not settle: Источник не устанавливает, блокируют ли антитела к M3-рецептору его функцию, влияют ли они на потоотделение, сохраняют ли снижение секреции после нормализации механики, а также восстанавливает ли удаление антител компонент SPV_8.

S4Partly answers it

Pemphigus vulgaris autoantibody profiling by proteomic technique. · PloS one · 2013

“M 3 subtype of muscarinic acetylcholine receptor ( AChR ) (CHRM3; 42%)”

Does not settle: Источник показывает распознавание CHRM3 антителами в сыворотках пациентов с пузырчаткой, но не устанавливает функциональную блокаду M3, снижение потоотделения, ответ на холинергический стимулятор, влияние удаления антител или независимость эффекта от механики железы и проходимости протока.

S6Background

Immunomodulatory treatment in postural tachycardia syndrome: A case series. · European journal of neurology · 2021

“Postural tachycardia syndrome (POTS) is a form of autonomic dysfunction characterized by symptoms of orthostatic intolerance, often accompanied by sudomotor dysfunction and gastrointestinal dysmotility.”

Does not settle: Источник не исследует аутоантитела к M3, их функциональную блокаду, ответ на холинергический стимулятор, механику или проходимость протока, SPV_8 либо эффект удаления антител.

S7BackgroundAbstract only

Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome? · Medical hypotheses · 2005

“Autoimmune reactions to these receptors may have parallels with muscarinic (e.g., Sjogren's syndrome) and nicotinic (e.g., MG) acetylcholine neurotransmission.”

Does not settle: Остаются открытыми связь аутоантител с рецептором M3 потовых желёз, функциональная блокада рецептора, реакция на холинергический стимулятор, роль механики протока и восстановление потоотделения после удаления антител.

S8Background

Demonstrating new-onset or worsened sudomotor function post-COVID-19 on comparative analysis of autonomic function pre-and post-SARS-CoV-2 infection. · eNeurologicalSci · 2023

“Sudomotor dysfunction was demonstrated in all participants.”

Does not settle: Источник не исследует аутоантитела к M3, их функциональную блокаду, рецепторный ответ на холинергический стимулятор, механику железы или протока, а также восстановление потоотделения после удаления антител.

S9Contradicts it

Non-invasive evaluation of sudomotor function in patients with myasthenia gravis. · Neurophysiologie clinique = Clinical neurophysiology · 2019

“We could not prove the presence of autonomic sympathetic dysfunction in our cohort of MG patients when assessed by Sudoscan®.”

Does not settle: Не устанавливает наличие или отсутствие аутоантител к M3, их функциональную блокаду, ответ на холинергический стимулятор, состояние механики протоков либо эффект удаления антител.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Can cells’ memory of force suppress sweating after skin softens, and can easing local forces restore it?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Определяет ли сохранённая клеток вокруг потерю после нормализации средней кожи, и восстанавливает ли функцию при неизменной ?

What this question is asking

The question concerns whether cells surrounding sweat glands retain effects of earlier physical forces that continue to reduce sweating. It asks whether this retained state explains reduced sweating even after the skin’s average stiffness has returned to normal. It also asks whether reducing forces around individual glands restores sweat output compared with leaving those forces unchanged, while keeping the signals that trigger sweat production the same. The framing assumes that average skin stiffness can recover while a lasting local cellular response remains; the supplied sources do not establish that sequence.

What the terms mean
Sweat gland
A structure in the skin that produces sweat. The question concerns whether forces and cells around this structure affect how much sweat reaches the surface.
Duct and duct patency
A duct is a channel carrying sweat from a gland to the skin surface; patency means that the channel is open. An open channel and adequate sweat production are distinct aspects of function.
Mechanical memory
A lasting cellular response to earlier physical forces or stiffness, continuing after the original conditions change. Here it names the proposed explanation for persistent reduced sweating, not a mechanism established by the supplied evidence.
Skin stiffness
How strongly skin resists being deformed. An average summarizes the measured region and does not specify the conditions around every individual gland.
Normalization
Return to a chosen normal or reference range. The supplied material does not specify that range for skin stiffness or sweating.
Local unloading or local relief
Reduction of physical forces around an individual gland. The input does not specify which forces are reduced or how the reduction is achieved.
Secretory stimulation
The signals that trigger a gland to produce and release sweat. Keeping these signals unchanged is intended to distinguish an effect of local force reduction from an effect of stronger sweat-producing signals.
Sweat output and sweat composition
Output is the amount of sweat released; composition is what the sweat contains. The question concerns recovery of output, whereas S5’s stated focus is composition.
Physiology
The study of how living structures function. Here it refers to how sweat glands produce sweat and determine its amount and contents.
Passive and active heat stress
Heat load arising from external warming or from physical activity, respectively. These are the conditions named in S5’s review objective, rather than tests of the local mechanical explanation proposed here.
What the question takes for granted
Premise could not be checked
Average skin stiffness can normalize while cells around sweat glands retain ; separately described and duct patency provide a basis for asking whether a local functional defect persists.

Sweat glands produce sweat, and their ducts are the channels through which it reaches the skin surface. The framing assumes that skin can regain its usual average resistance to deformation while nearby cells retain a lasting response to earlier forces. If that sequence occurs, it would allow the question to distinguish overall skin recovery from a continuing problem around individual glands.

The supplied material does not establish retained cellular around sweat glands, recovery of average stiffness followed by persistent reduced sweating, or the separate duct findings invoked in the gap detail. S5 and S6 state the scope of reviews of sweat physiology. S10 reports that unspecified changes did not reverse during a five-week recovery period, but its supplied excerpt does not identify those changes or establish the sequence assumed here. S3 has no supplied quotation. This evidence is too thin to verify or refute the premise.S3S5S6S10

The same question asked without the part nothing read establishes:

  • When average skin stiffness returns to normal, does a lasting response to earlier forces in cells around sweat glands account for any remaining reduction in sweating?
  • Does reducing forces around sweat glands increase sweat output when the signals that trigger sweat production remain unchanged?
What turns on the answer
  • Retained memory suppresses sweating; local relief restores it Under this outcome, earlier forces would leave surrounding cells in a state that continues to interfere with sweating after average skin stiffness recovers. Reducing local forces would restore output under unchanged sweat-producing signals, so average stiffness alone would be insufficient to establish functional recovery.
  • Retained memory suppresses sweating; local relief does not restore it Under this outcome, the lasting cellular response would continue to suppress sweating after both average softening and local force reduction. Removing the current local force would therefore be insufficient to reverse the retained state or its functional consequence.
  • Local relief restores sweating without a role for retained memory Under this outcome, current forces around glands would limit sweating, and reducing them would restore output under unchanged signals. Improvement after local relief would therefore not by itself establish that cells had retained a memory of earlier forces.
  • Neither retained memory nor local relief explains recovery Under this outcome, the proposed lasting cellular response would not account for reduced sweating, and reducing local forces would not restore output. The question’s proposed explanation and correction would leave the functional defect unresolved.
Why it matters

The question distinguishes recovery of an average skin measurement from recovery of sweat production. If cells around individual glands retain a force-related state that suppresses sweating, a normal average stiffness measurement could conceal a continuing functional problem. If reducing local forces restores sweating under the same sweat-producing signals, local mechanical conditions would matter to functional recovery. If it does not, treating average softening or local force reduction as sufficient for recovery could leave reduced sweating unexplained and unresolved.

What is already established

RL-1 и RL-3 описаны раздельно; средняя не характеризует окружение каждой железы.

What would have to be true

восстанавливается за установленные недели; сохраняется в без накопления локального уплотнения.

What is missing

Не определено, сохраняет ли локальная функциональный дефект после нормализации средних показателей и поддаётся ли он обратимой коррекции.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Стойкое снижение поддерживают связанные с железой , функционально блокирующие . После нормализации одинаковая концентрация вызывает меньший . Механические изменения сопутствуют нарушению, а его сохраняющийся носитель представляет собой . Удаление блокирующих антител должно восстановить потовый компонент без изменения и .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Выделенная из образца с дефектом подавляет в и контрольных желёз при неизменной . После удаления переносимый эффект исчезает, а при её возвращении воспроизводится. Сохраняется ответ на независимо проверенный . Отсутствие при подтверждённом извлечении связанных антител опровергает гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable suppression, disappearance and restoration of the effect, a preserved bypass response, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Доступны с , и выделение . необходимо дополнить . В без проверяются антитела, присутствовавшие до получения ткани; короткая сама по себе не предполагается достаточной для нового .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Выделенная из образца с дефектом подавляет в и контрольных желёз при неизменной . После удаления переносимый эффект исчезает, а при её возвращении воспроизводится. Сохраняется ответ на независимо проверенный . Отсутствие при подтверждённом извлечении связанных антител опровергает гипотезу.

  • What would separate them

    Altered aquaporin placement may reduce sweat output by letting water return through duct walls predicts: При одинаковой прямой стимуляции образование жидкости в сохраняется, а объём на выходе снижается. изолированного неповреждённого выявляет повышенный перенос воды наружу при физиологическом и сохранённом удержании . Снижение этого градиента восстанавливает выход жидкости без изменения , и их числа. Отсутствие избыточного переноса воды при достаточной опровергает гипотезу.

  • What would separate them

    Mechanical history may uncouple calcium entry from chloride flow within sweat-gland cells predicts: При одинаковом суммарном восстановлении и коррекция обоих звеньев в одних клетках восстанавливает значительно сильнее, чем распределение этих коррекций между разными клетками. Различие сохраняется при одинаковой и . Если раздельная коррекция даёт такое же восстановление либо исходное сохранено, гипотеза отвергается.

  • What would separate them

    Selecting skin samples by final stiffness may create a false link between past load and sweating predicts: В анализе всех заранее эффект истории отсутствует в пределах заранее установленной . Он появляется или меняет знак только после ограничения узким диапазоном итоговой . В одних и тех же желёз не даёт специфического устойчивого восстановления относительно . Сохранение эффекта в полном рандомизированном наборе опровергает это объяснение.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.